Mental Health Clinics in Uxbridge, MA Accepting Medicare
4 Mental Health Clinics found. Showing 1 - 4
 Mindful Healing Counseling Services Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2 S Main St Ste 203, Uxbridge, MA 01569 Phone: 508-389-3627 |
Community Impact Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 9 Murphys Way, Uxbridge, MA 01569 Phone: 401-339-6686 |
Healy Behavioral Services Llc Behavior Technician Medicare: Not Enrolled in Medicare Practice Location: 280 Chocolog Rd, Uxbridge, MA 01569 Phone: 508-278-2250 |
Dawn Mccarthy Lmhc Pc Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 738 W Hartford Ave, Uxbridge, MA 01569 Phone: 508-266-5303 |
News Archive
iCo Therapeutics incurs total comprehensive loss of $738,607 for second quarter 2015
iCo Therapeutics, today reported financial results for the quarter ended June 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").
UCL research opens up new way to treat neurological disorders
The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.
Members of Congress say they will advocate for more health funding in Rwanda
Five members of Congress who are visiting Rwanda said they will advocate for more funding for the country's health sector, New Times/allAfrica.com reports. The delegation includes Marcia Fudge (D-Ohio), Sheila Jackson Lee (D-Texas), Jack Kingston (R-Ga.), Gregory Meeks (D-N.Y.), and Melvin Watt (D-N.C.) (Musoni, 9/1).
TransPharma Medical completes ViaDerm-GLP1 agonist Phase 1a trial for type II diabetes
TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1a trial of ViaDerm-GLP1 agonist which is being developed for the treatment of diabetes mellitus type II.
Got food allergies? Add milk to the worries for your meal
Since her son Matt was an infant, Lynda Mitchell knew he had a milk allergy. She controlled the symptoms by switching his baby formula. But when he was 1, Halloween proved horrifying. While trick-or-treating in a pumpkin costume, Matt grabbed a chocolate bar and bit through the wrapper. Although he spit out the candy, his violent allergic reaction morphed into a mess of hives, swelling and labored breathing. He ended up in the emergency room.
› Verified 2 days ago